摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[1-benzothiene-2-yl-(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane | 761424-75-3

中文名称
——
中文别名
——
英文名称
[1-benzothiene-2-yl-(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane
英文别名
[1-benzothien-2-yl(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane;[1-benzothiophen-2-yl-(5-bromo-2-fluorophenyl)methoxy]-tert-butyl-dimethylsilane
[1-benzothiene-2-yl-(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane化学式
CAS
761424-75-3
化学式
C21H24BrFOSSi
mdl
——
分子量
451.475
InChiKey
JQEYTUYTMFEZKU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    474.5±40.0 °C(Predicted)
  • 密度:
    1.272±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    7.91
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    37.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-内酯[1-benzothiene-2-yl-(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane正丁基锂氯化铵 作用下, 以 四氢呋喃正己烷 为溶剂, 以50.2%的产率得到1-C-[3-(1-benzothien-2-yl{tert-butyl-(dimethyl)silyloxy}methyl)-4-fluorophenyl]-2,3,4,6-tetra-O-benzyl-D-glucopyranose
    参考文献:
    名称:
    EP2105442
    摘要:
    公开号:
  • 作为产物:
    描述:
    依格列净中间体 以78.0的产率得到[1-benzothiene-2-yl-(5-bromo-2-fluorophenyl)methoxy](tert-butyl)dimethylsilane
    参考文献:
    名称:
    Method for producing C-glycoside derivative and intermediate for synthesis thereof
    摘要:
    本发明提供了一种生产C-糖苷衍生物的方法,该方法可以以高产率和低成本生产符合环保要求的C-糖苷衍生物,且适用于工业应用。该C-糖苷衍生物可用于治疗和预防糖尿病,如胰岛素依赖型糖尿病(1型糖尿病)、非胰岛素依赖型糖尿病(2型糖尿病)及其他糖尿病相关疾病,包括胰岛素抵抗性疾病和肥胖症。
    公开号:
    US08198464B2
点击查看最新优质反应信息

文献信息

  • [EN] C-GLYCOSIDE DERIVATIVES AND SALTS THEREOF<br/>[FR] DERIVES DE C-GLYCOSIDE ET SELS CORRESPONDANTS
    申请人:YAMANOUCHI PHARMA CO LTD
    公开号:WO2004080990A1
    公开(公告)日:2004-09-23
    A C-glycoside derivative represented by the following general formula (I) or its salt which is a compound useful as a Na+-glucose co-transportation inhibitor in a remedy for, e.g., diabetes, in particular, insulin-independent diabetes (type 2 diabetes) and insulin-dependent diabetes (type 1 diabetes), as well as a remedy for insulin resistance diseases and various diseases relating to diabetes including obesity. This compound is characterized in that the ring B is bonded to the ring A via -X- and the ring A is bonded directly to a sugar residue.
    以下是一种由下述通式(I)表示的C-糖苷衍生物或其盐,该化合物在治疗糖尿病(尤其是胰岛素非依赖性糖尿病(2型糖尿病)和胰岛素依赖性糖尿病(1型糖尿病))以及治疗胰岛素抵抗症和与糖尿病相关的各种疾病(包括肥胖症)中有用,作为Na+-葡萄糖共同转运抑制剂。该化合物的特点在于,环B通过-X-与环A连接,并且环A直接与糖残基连接。
  • C-glycoside derivatives and salts thereof
    申请人:Imamura Masakazu
    公开号:US20060122126A1
    公开(公告)日:2006-06-08
    The present invention provides C-glycoside derivatives and salts thereof, wherein B ring is bonded to A ring via —X— and A ring is directly bonded to the glucose residue, and it is usable as a Na + -glucose cotransporter inhibitor, especially for a therapeutic and/or preventive agent for diabetes such as insulin-dependent diabetes (type 1 diabetes) and insulin-independent diabetes (type 2 diabetes), as well as diabetes related diseases such as an insulin-resistant diseases and obesity.
    本发明提供了C-糖苷衍生物及其盐,其中B环通过—X—与A环连接,并且A环直接与葡萄糖残基连接,可用作Na+-葡萄糖共转运体抑制剂,特别是用于治疗和/或预防糖尿病,如胰岛素依赖性糖尿病(1型糖尿病)和胰岛素非依赖性糖尿病(2型糖尿病),以及与糖尿病相关的疾病,如胰岛素抵抗性疾病和肥胖症。
  • Method for producing C-glycoside derivative and intermediate for synthesis thereof
    申请人:Astellas Pharma Inc.
    公开号:US08198464B2
    公开(公告)日:2012-06-12
    The present invention provides a method for producing a C-glycoside derivative, which can produce the C-glycoside derivative at a high yield and at a low cost, which conforms to environmental protection, and which is applicable industrially. The C-glycoside derivative is useful for treating and preventing diabetes such as insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes (type 2 diabetes) and the like and various diabetes-related diseases including insulin-resistant diseases and obesity.
    本发明提供了一种生产C-糖苷衍生物的方法,该方法可以以高产率和低成本生产符合环保要求的C-糖苷衍生物,且适用于工业应用。该C-糖苷衍生物可用于治疗和预防糖尿病,如胰岛素依赖型糖尿病(1型糖尿病)、非胰岛素依赖型糖尿病(2型糖尿病)及其他糖尿病相关疾病,包括胰岛素抵抗性疾病和肥胖症。
  • METHOD FOR PRODUCING C-GLYCOSIDE DERIVATIVE AND INTERMEDIATE FOR SYNTHESIS THEREOF
    申请人:Komenoi Kousuke
    公开号:US20100094025A1
    公开(公告)日:2010-04-15
    The present invention provides a method for producing a C-glycoside derivative, which can produce the C-glycoside derivative at a high yield and at a low cost, which conforms to environmental protection, and which is applicable industrially. The C-glycoside derivative is useful for treating and preventing diabetes such as insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes (type 2 diabetes) and the like and various diabetes-related diseases including insulin-resistant diseases and obesity.
    本发明提供了一种生产C-糖苷衍生物的方法,该方法可以以高产率和低成本生产C-糖苷衍生物,符合环保要求,并适用于工业应用。C-糖苷衍生物可用于治疗和预防糖尿病,如胰岛素依赖性糖尿病(1型糖尿病)、非胰岛素依赖性糖尿病(2型糖尿病)以及各种与糖尿病相关的疾病,包括胰岛素抵抗性疾病和肥胖症。
  • WO2008075736A1
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物